GlassScriptPhysician profile
Christoper R Hill
NPI 1013977016
$5,076.26
in general payments reported to CMS, 2019-2025
41 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,224 · 2020: $1,227 · 2021: $1,170 · 2022: $884 · 2023: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $571.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $545.41 | 2019-2023 | Belbuca, Xtampza |
| Eisai INC. | $505.46 | 2020-2022 | |
| Scilex Pharmaceuticals INC. | $498.72 | 2019-2023 | Ztlido |
| Biodelivery Sciences International, INC. | $349.20 | 2019-2021 | |
| Lilly USA, LLC | $309.73 | 2019-2023 | Emgality, Reyvow |
| Amgen INC. | $307.49 | 2019-2022 | |
| Ibsa Pharma INC. | $292.31 | 2020-2023 | Tirosint, Licart |
| Forte Bio-Pharma LLC | $230.16 | 2020-2023 | Prolate, Nalocet |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $207.79 | 2020-2022 | |
| Daiichi Sankyo INC. | $193.85 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $177.16 | 2022 | |
| Pfizer INC. | $173.57 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $169.18 | 2019-2021 | |
| Redhill Biopharma INC. | $121.27 | 2020-2022 | |
| Grt US Holding, INC. | $95.30 | 2020-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christoper Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.